As of 2025-09-15, the EV/EBITDA ratio of ImmunoGen Inc (IMGN) is -105.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMGN's latest enterprise value is 8,216.60 mil USD. IMGN's TTM EBITDA according to its financial statements is -77.98 mil USD. Dividing these 2 quantities gives us the above IMGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 15.7x | 14.4x |
| Forward P/E multiples | 19.2x - 35.9x | 27.6x |
| Fair Price | (3.54) - (2.57) | (4.03) |
| Upside | -111.3% - -108.2% | -112.9% |
| Date | EV/EBITDA |